Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CTS-1027: Phase II started

Conatus began a 4-week, double-blind, placebo-controlled, multi-dose, U.S. Phase

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE